Insider Trading February 18, 2026

Abacus Global Management Co-Founder Executes $20,001 Share Sale to Cover RSU Taxes

Matthew Ganovsky sells 2,386 shares; company also advances asset-based finance strategy and moves listings to the NYSE

By Caleb Monroe ABX
Abacus Global Management Co-Founder Executes $20,001 Share Sale to Cover RSU Taxes
ABX

Matthew Ganovsky, co-founder and president of Abacus Global Management, sold 2,386 shares on February 18, 2026, for roughly $20,001 in a transaction disclosed on a Form 4. The sale was executed to satisfy tax withholding obligations tied to recently vested restricted stock units. The filing also details Ganovsky's remaining direct holdings and outstanding RSU schedules. Separately, Abacus announced a new asset-based finance strategy and its planned transfer of listings to the New York Stock Exchange under the ticker ABX effective December 30, 2025.

Key Points

  • Matthew Ganovsky sold 2,386 shares on February 18, 2026 at $8.383 per share, totaling about $20,001.
  • The sale was executed to meet tax withholding obligations connected to vested RSUs; Ganovsky used a sell-to-cover election.
  • Abacus announced a new asset-based finance strategy targeting a market valued at over $20 trillion and plans to move listings to the NYSE under ticker ABX on December 30, 2025.

Matthew Ganovsky, the Co-Founder and President of Abacus Global Management, Inc. (EXCHANGE:ABX), reported a small sale of company shares this week in a filing with the Securities and Exchange Commission.

According to the Form 4 filing, Ganovsky sold 2,386 shares of the issuer's common stock on February 18, 2026 at a per-share price of $8.383, resulting in proceeds of approximately $20,001.

The filing also notes a prior acquisition tied to the vesting of restricted stock units. On February 13, 2026, Ganovsky acquired 8,000 shares of common stock at $8.40 apiece, for a total value of $67,200. Those shares were the result of RSUs previously granted to Ganovsky on February 13, 2024, under a schedule that vests one-third of the award on each of the first three anniversaries of the grant date.

Following the sale on February 18, the filing states that Ganovsky directly owns 8,609,624 shares of Abacus Global Management common stock. The reported direct holdings include time-based RSUs that remain outstanding and will convert to the same number of common shares upon vesting as previously documented on Table II of the filing.

Specifically, the filing highlights 81,856 time-based RSUs granted on April 3, 2025, with one-third of that award scheduled to vest on each of March 27, 2026, March 27, 2027 and March 27, 2028. It also references the RSUs granted on February 13, 2024, noting that a third of the total grant vests on each anniversary, and that 8,000 shares remain and are scheduled to vest on February 13, 2027.

The Form 4 clarifies the purpose behind the recent sale: the shares relinquished on February 18 were sold to cover tax withholding obligations associated with the vesting and settlement of RSUs. Ganovsky elected a "sell to cover" method to satisfy those tax obligations.

The filing also makes clear that it does not include certain shares of common stock held in trusts established by Ganovsky. Those trusts hold 3,847,046 shares, of which Ganovsky disclaims beneficial ownership, according to the filing.


In separate company developments disclosed in the same filing, Abacus Global Management announced two strategic initiatives.

  • First, the firm said it will launch a new asset-based finance strategy within its Asset Group, targeting a market the company values at more than $20 trillion. The initiative will be led by Monty Cook, Head of Private Credit at Abacus, and Elena Plesco, Chief Capital Officer. The filing notes both executives bring experience from prior roles at Varde Partners and KKR, respectively.
  • Second, Abacus will transfer the listings of its common stock and its 9.875% Fixed Rate Senior Notes due 2028 from the Nasdaq Capital Market to the New York Stock Exchange. The company said trading on the NYSE is expected to begin on December 30, 2025 under the ticker ABX.

These filings together provide a detailed snapshot of one executive's recent personal transactions, the remaining equity and time-based awards in play, and concurrent corporate moves intended to expand product capabilities and alter trading venue. The disclosure frames the February 18 sale as a tax-related, administrative action rather than an open-market investment decision.

Where the filing leaves open questions - such as any additional planned sales or future vesting beyond the schedules listed - the document confines its scope to the specific transactions, outstanding RSUs, trust-held shares, the newly announced strategy, and the listing transfer plans reported within.

Risks

  • Future vesting schedules could create additional tax withholding events and potential share sales that impact public float or insider ownership metrics - relevant to equity investors and capital markets participants.
  • The company’s strategic shift into an asset-based finance strategy may involve execution risk as it launches a new product line within its Asset Group - relevant to asset management and private credit sectors.
  • Transfer of listings from Nasdaq to the NYSE introduces operational and market-structure changes that could affect liquidity or trading dynamics for holders of common stock and the 9.875% Fixed Rate Senior Notes due 2028.

More from Insider Trading

Amgen Finance VP Sells $375,790 Worth of Shares as Analysts Split on Outlook Feb 20, 2026 Weyerhaeuser Director Adds to Stake with $101,400 Purchase Feb 20, 2026 Mitsui Sumitomo Boosts Stake in W. R. Berkley with $35.7 Million Purchases Feb 20, 2026 Hyatt CFO Sells $304,063 in Class A Shares; Transaction Conducted Under Pre-arranged Plan Feb 20, 2026 PennyMac Chairman Sells $1.22 Million in Stock as Q4 Miss and Sector Volatility Shadow Shares Feb 20, 2026